Aton (EPA:ALTAO)
0.0064
-0.0002 (-3.03%)
Nov 12, 2026, 11:45 AM CET
Aton Company Description
Aton operates as a bioscience company in France. It engages in preclinical and clinical services, production of monoclonal antibodies, and laboratory equipment production, as well as provision of human tissues.
The company is involved in development of biomaterials and reagents for diagnostics, as well as preclinical research services.
Aton was founded in 1998 and is headquartered in Strasbourg, France.
Aton
| Country | France |
| Founded | 1998 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Ayikoele Atayi |
Contact Details
Address: 850 Boulevard Sébastien Brant Strasbourg, 67400 France | |
| Phone | 33 9 72 56 94 99 |
| Website | aton-group.com |
Stock Details
| Ticker Symbol | ALTAO |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0004153930 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Hadrien Lanvin | Deputy Chief Executive Officer and Director |
| Ayikoele Atayi | GM and Chair of the Board of Directors |